Financial Performance - Zepp Health Corporation reported revenues of US42.5millionforQ32024,adecreaseof48.912.5 million in Q3 2024, compared to an operating income of US1.4millioninQ32023,largelyduetolowersalesvolume[13][14]ProductandMarketDevelopments−Amazfitbrandedsalessawa1010.9 million, accounting for 25.6% of revenues, reflecting a 4.8% year-over-year increase as the company invests in new technologies, including AI [8] Marketing and Operational Strategies - Selling and marketing expenses increased by 21.9% year-over-year to US11.9million,representing28.07.0 million, largely due to foreign exchange rate fluctuations [11] Liquidity and Capital Resources - As of September 30, 2024, the company had cash and cash equivalents of US127.7million,maintainingasimilarlevelcomparedtothepreviousquarter,whichprovidesarunwayforfutureinvestments[17]−ThecompanyrecordedinventoryofUS76.6 million, reflecting a 6.5% increase from the previous quarter but a 29.0% decrease compared to the same period in 2023 [18] Future Outlook - For Q4 2024, management expects net revenues to be between US55millionandUS70 million, indicating a growth of 29% to 65% for self-branded products compared to Q3 2024 [22]